![](https://www.Immune-System-Research.com/"wp-content/uploads"/2023/03/Omaveloxolone-Activates-Nrf2-and-Inhibits-NF-κB-for-Friedreichs-Ataxia-Research-2023-0318.jpg)
Omaveloxolone (RTA 408) is an agent for Friedreich’s Ataxia. And it acts through a combination of activation of the antioxidative…
Alzheimer’s disease (AD) is a chronic neurodegenerative disease that usually starts slowly and gradually worsens over time. In this study,…